Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 26, 2025
Researchers refine experimental gene therapy for herpes
Treatment sharply reduced viral shedding in laboratory mice
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
Herpes simplex virus mistyping due to inter-species recombination
From the University of Washington, the Vaccine and Infectious Disease Division
Despite early rise, longterm ART decreases HSV shedding
From the Corey lab, Vaccine and Infectious Disease Division
Models aren’t just pretty
From the Schiffer lab, Vaccine and Infectious Disease Division
Experimental herpes drug pritelivir more effective than standard treatment
Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows
Halting herpes' transmission
New Hutch study predicts threshold of viral load for passing herpes from one person to another
Genital herpes can spread even when lesions aren't present
Largest study of herpes simplex virus type 2 to date finds asymptomatic carriers can transmit virus to partners
Stemming the spread of STD's
International center-led trial finds that a daily dose of an antiviral drug halves transmission of genital herpes, may lessen other STD infections